A detailed history of Clari Vest Asset Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 102,822 shares of VYGR stock, worth $601,508. This represents 0.09% of its overall portfolio holdings.

Number of Shares
102,822
Previous 100,123 2.7%
Holding current value
$601,508
Previous $932,000 12.77%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$7.42 - $10.54 $20,026 - $28,447
2,699 Added 2.7%
102,822 $813,000
Q1 2024

May 06, 2024

BUY
$7.15 - $10.84 $266,516 - $404,061
37,275 Added 59.31%
100,123 $932,000
Q4 2023

Feb 13, 2024

BUY
$6.28 - $8.81 $85,081 - $119,357
13,548 Added 27.48%
62,848 $530,000
Q2 2023

Aug 14, 2023

BUY
$6.94 - $13.99 $342,142 - $689,707
49,300 New
49,300 $564,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $226M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.